Detection of tumors with 19F magnetic resonance imaging

Investigative Radiology

Volumn 23, Issue 5, 1988, Pages 361-364

  Ratner, Adam V ^a   Muller, Holde H ^a   Bradley Simpson, Beverly ^a   Johnson, Danna E ^b   Hurd, Ralph E ^c   Sotak, Chris ^c   Young, Stuart W ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GENERAL ELECTRIC COMPANY   (United States)

Author keywords

Cancer imaging; Contrast media; Fluorine; Magnetic resonance imaging; Nuclear magnetic resonance

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; FLUOROCARBON; PERFLUOROOCTYL BROMIDE; FLUORINE;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; EXPERIMENTAL NEOPLASM; MOUSE; MOUSE STRAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; ANIMAL EXPERIMENT; BRAIN TUMOR; CANCER GRAFT; COMPUTER ANALYSIS; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; NONHUMAN; TUMOR RIF 1;

ANIMAL; CONTRAST MEDIA; FLUOROCARBONS; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023821392     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/00004424-198805000-00006     Document Type: Article

References (13)

1. Young SW, Enzmann DR, Long DM, Muller HH. Perfluorooctyl bromide contrast enhancement of malignant neoplasms: preliminary observations. AJR 1981;137:141-146.
2. Mattrey RF, Long DM, Multer F, Mitten R. Higgins CB. Perfluo rooctyl bromide: a reticuloendothelial specific and tumor imaging agent for computed tomography. Radiology 1982;145:755-758.
3. Ratner AV, Hurd R, Muller HH, et al. 19F Magnetic resonance imaging of the reticuloendothelial system. Magnetic Resonance in Medicine 1987;5(6):548-554.
4. McFarland E, Koutcher JA, Rosen BR, Teicher B, Brady TJ. In vivo 19F NMR imaging. J Comput Assist Tomogr 1985;9:8-15.
5. Joseph PM, Fishman JE, Mukherji B, Sloviter HA. In vivo 19FNMR imaging of the cardiovascular system. J Comput Assist Tomogr 1985;9(6):1012-1019.
6. Long DM, Multer FK, Greenburg AG, Peskin GW, Lasser EC, Wichman W. Tumor imaging with x-rays using macrophage uptake of radioopaque fluorocarbon emulsions. Surgery 1978;84: 104-112.
7. Sartoris DJ, Guerra J, Mattrey RF, et al. Perfluorooctyl bromide as a contrast agent for computed tomographic imaging of septic and aseptic arthritis. Invest Radiol 1986;21:49-55.
8. Mattrey RF, Andre MP. Ultrasonic enhancement of myocardial infarction with perfluorocarbon compounds in dogs. Am J Cardiol 1984;54:206-219.
9. Mattrey RF, Leopold GR, van Sonneberg E, Gosink BB, Scheible FW, Long DM. Perfluorochemicals as liver and spleen seeking ultrasound contrast agents. J Ultrasound Med 1983;2:173-176.
10. Martin JF, Mattrey RF. 19F chemical shift imaging of perfluorooctyl bromine. SMRM Fifth Annual Meeting Book of Abstracts 1986;3:840.
11. Nunnally RL, Babcock EE. Cardiac imaging utilizing 19F imaging. Radiology 1986;161:124 [abstract].
12. Fishman JE, Joseph PM, Mukheiji B, Sloviter HA. Organ and tumor imaging using 19F MR imaging. Radiology 1986;161:124 [abstract].
13. Enzmann DR, Young SW. Applications of perfluorinated compounds as contrast agents in computed tomography. J Comput Assist Tomogr 1979;3:662-626.